Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C2orf81 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | MTERF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | TADA3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | TMEM14C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | PRDM2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | LENG9 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | LMOD1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | ZAR1L | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | IL6R | FIMM | pan-cancer | AAC | 0.63 | 0.005 |
mRNA | ANGPTL8 | FIMM | pan-cancer | AAC | -0.43 | 0.005 |